Sympathetic Overactivity in Essential Hypertension
NCT00541619 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-04-17
Summary
The primary objective of the study is whether subjects with hypertension and proteinuria display increased sympathetic nerve activity compared to hypertensive subjects without proteinuria and normotensive controls.
Conditions
- Hypertension
- Proteinuria
Sponsors & Collaborators
-
University of Erlangen-Nürnberg Medical School
lead OTHER
Principal Investigators
-
Roland Veelken, MD · Principal Investigator
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Renal Sympathetic Denervation Combined With Aorticorenal Ganglion Ablation for Treatment of Hypertension
NCT06864962 ·Status: WITHDRAWN ·Phase: NA
-
Sympathetic Activity and Cardiometabolic Complications
NCT04495231 ·Status: COMPLETED
-
Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control
NCT05513430 ·Status: COMPLETED
-
Renal Denervation in Treatment Resistant Hypertension
NCT01687725 ·Status: COMPLETED
-
Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation
NCT03243045 ·Status: COMPLETED
-
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022 ·Status: COMPLETED ·Phase: NA
-
Genetic Based Analysis in Hypertensive Patients
NCT04321044 ·Status: COMPLETED ·Phase: NA
-
Patient Preference in Blood Pressure Therapy
NCT03548623 ·Status: COMPLETED
-
Impact of Aerobic Exercise Training on Sympathetic Vasoconstriction and Vascular Function in Essential Hypertension
NCT03778489 ·Status: COMPLETED ·Phase: NA
-
Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension
NCT02653222 ·Status: TERMINATED ·Phase: PHASE2
-
Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure
NCT03415906 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Electrical Baroreflex Stimulation on Sympathetic Activity, Renal Hemodynamics, and Insulin Sensitivity
NCT01355510 ·Status: UNKNOWN
-
Genetic and Environmental Determinants of Hypertension
NCT00005149 ·Status: COMPLETED
-
Urinary Kallikrein and Hypertension: A Prospective Study
NCT00005261 ·Status: COMPLETED
-
Renal Sympathetic Denervation in Mild Refractory Hypertension
NCT01656096 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
NCT01850901 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation
NCT02164435 ·Status: UNKNOWN ·Phase: NA
-
Mechanism of Masked Hypertension - Intervention
NCT04121299 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Trial From RENEWAL RDN Registry)
NCT01918111 ·Status: TERMINATED ·Phase: PHASE4
-
Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.
NCT02039492 ·Status: COMPLETED ·Phase: NA
-
Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
NCT01737138 ·Status: UNKNOWN ·Phase: NA
-
Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction
NCT01583881 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Transcatheter Renal Artery Sympathetic Denervation Observational Study
NCT05744986 ·Status: UNKNOWN
-
Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
NCT06626113 ·Status: RECRUITING
-
Renal Sympathetic Denervation From the Adventitia on Resistant Hypertension（RSDARH）
NCT03758196 ·Status: UNKNOWN ·Phase: NA